OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2017.6638 OL-0-0-6638 Articles Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK/AP-1 signaling pathway in human breast cancer MCF-7 cells KimJeong-Mi 1 * NohEun-Mi 1 * SongHyun-Kyung 1 LeeMinok 1 LeeSoo Ho 2 ParkSueng Hyuk 2 AhnChan-Keun 3 LeeGuem-San 4 ByunEui-Baek 5 JangBeom-Su 5 KwonKang-Beom 1 2 LeeYoung-Rae 1 6 7 8 Center for Metabolic Function Regulation, Wonkwang University School of Korean Medicine, Iksan, North Jeolla 570-749, Republic of Korea Department of Korean Physiology, Wonkwang University School of Korean Medicine, Iksan, North Jeolla 570-749, Republic of Korea Department of Otolaryngology and Dermatology, Wonkwang University School of Korean Medicine, Iksan, North Jeolla 570-749, Republic of Korea Department of Herbology, Wonkwang University School of Korean Medicine, Iksan, North Jeolla 570-749, Republic of Korea Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, North Jeolla 580-185, Republic of Korea Department of Oral Biochemistry, School of Dentistry, Wonkwang University, Iksan, North Jeolla 570-749, Republic of Korea Institute of Biomaterials Implant, School of Dentistry, Wonkwang University, Iksan, North Jeolla 570-749, Republic of Korea Integrated Omics Institute, Wonkwang University, Iksan, North Jeolla 570-749, Republic of Korea Correspondence to: Professor Kang-Beom Kwon, Department of Korean Physiology, Wonkwang University School of Korean Medicine, 460 Iksandae-ro, Iksan, North Jeolla 570-749, Republic of Korea, E-mail: desson@wku.ac.kr Professor Young-Rae Lee, Department of Oral Biochemistry, School of Dentistry, Wonkwang University, 460 Iksandae-ro, Iksan, North Jeolla 570-749, Republic of Korea, E-mail: mindyr@wku.ac.kr

Contributed equally

 09 2017 20 07 2017 14 3 3594 3600 16022017 09062017 Copyright: © Kim et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Cancer cell invasion is crucial for metastasis. A major factor in the capacity of cancer cell invasion is the activation of matrix metalloproteinase-9 (MMP-9), which degrades the extracellular matrix. Salvia miltiorrhiza has been used as a promotion for blood circulation to remove blood stasis. Numerous previous studies have demonstrated that S. miltiorrhiza extracts (SME) decrease lipid levels and inhibit inflammation. However, the mechanism behind the effect of SME on breast cancer invasion has not been identified. The inhibitory effects of SME on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MMP-9 expression were assessed using western blotting, reverse transcription-quantitative polymerase chain reaction and zymography assays. MMP-9 upstream signal proteins, including mitogen-activated protein kinases and activator protein 1 (AP-1) were also investigated. Cell invasion was assessed using a matrigel invasion assay. The present study demonstrated the inhibitory effects of the SME ethanol solution on MMP-9 expression and cell invasion in TPA-treated MCF-7 breast cancer cells. SME suppressed TPA-induced MMP-9 expression and MCF-7 cell invasion by blocking the transcriptional activation of AP-1. SME may possess therapeutic potential for inhibiting breast cancer cell invasiveness.

 Salvia miltiorrhiza extract human matrix metalloproteinase-9 invasion activator protein 1 breast cancer MCF-7 cell line Introduction

Salvia miltiorrhiza roots have traditionally been used for the treatment of gynecological disorders in Chinese medicine (1). S. miltiorrhiza extracts (SME) have been suggested to decrease lipid levels and inhibit inflammation (2–4), and have demonstrated cytotoxic effects on cells derived from various types of human cancer, including the lung, colon and pancreas (5–7). Previously, Tanshinone II-A, extracted from S. miltiorrhiza, inhibited invasion and metastasis of human carcinoma cells (8,9). More notably, certain studies have demonstrated that SME exhibits antitumor effects in breast cancer cells (10,11). However, the inhibitory effect of SME on breast cancer invasion was not known.

Breast cancer is a malignant tumor with the ability to spread beyond the breast tissue. The patients with breast cancer exhibited a high mortality rate (12), primarily caused by metastasis and invasion of cancer cells. Consequently, the primary approach for breast cancer treatment has been the development of effective anti-metastasis and anti-invasion drugs (13,14).

Invasion and metastasis of cancer cells are characterized by the degradation of the extracellular matrix (ECM) by proteases secreted from cancer cells (15,16). A total of ~24 types of human matrix metalloproteinases (MMPs) are synthesized and secreted from cells (17,18). Of those, MMP-9 is well known as a key enzyme that regulates breast cancer cell invasion (19). High concentrations of MMP-9 were identified in breast cancer tissue compared with those in normal breast tissue (20). A variety of stimulators such as tissue plasminogen activator (TPA), tumor necrosis factor-α and epidermal growth factor may increase the expression of MMP-9 in cancer cells (21–24).

Cytokine and TPA-mediated MMP-9 expression is controlled by the transcription factors, nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) in cancer cells (19,25,26). AP-1 is the collective name for referring to dimeric transcription factor proteins composed of Jun proto-oncogene, Fos proto-oncogene and the activated transcription factor protein families (27). Dimerized Jun/Fos bind to specific AP-1 sites of DNA, but their functions depend on cell type and activating agent (28–31). NF-κB forms a complex with its cellular protein inhibitor (inhibitory κBα; IκBα) and thereby remains inactive in the cytoplasm (32). When TPA phosphorylates IκB this complex dissociates, releasing NF-κB, which then translocates to the nucleus where it interacts with DNA binding sites on the MMP-9 promoter (33,34). Previously, Hsieh and Wu (28) suggested that S. miltiorrhiza roots have capacity to regulate NF-κB.

In the present study, it has been hypothesized that SME may exhibit anticancer properties through the inhibition of cell invasion. Therefore, the molecular mechanism by which SME affects the invasiveness of the breast cancer MCF-7 cell line was investigated. SME reduced TPA-induced cell invasion via the mitogen-activated protein kinase (MAPK)/AP-1 signaling pathways, and decreased MMP-9 expression was associated with the extent of the inhibition of breast cancer cell invasion.

 Materials and methods <sec> <title>Cell and reagents

MCF-7 cells were acquired from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in Dulbecco's modified Eagle medium (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 1% antibiotics (10,000 U/ml penicillin, 10,000 µg/ml streptomycin, 25 µg/ml amphotericin B) and 10% fetal bovine serum (Thermo Fisher Scientific, Inc.) at 37°C in an incubator with 5% CO2 saturation. DAPI, TPA, dimethyl sulfoxide and anti-β-actin antibody were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Antibodies against MMP-9 (catalog no. 12759), inhibitory κ B kinase (IKK)α (catalog no. 2682), IKKβ (catalog no. 2678), proliferating cell nuclear antigen (PCNA; catalog no. 7907), IκBα (catalog no. 371), transcription factor p65 (catalog no. 372), and horseradish peroxidase (HRP)-conjugated immunoglobulin G (IgG) (catalog no. 2004, 2005) were obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Antibodies against c-Jun N-terminal kinase (JNK; catalog no. 9252), p38 (catalog no. 9212), extracellular signal-regulated kinase (ERK; catalog no. 9102), phosphorylated (p)-JNK (catalog no. 9252), p-p38 (catalog no. 9211), p-ERK (catalog no. 9101), p-c-Jun (catalog no. 9261), p-IκBα (catalog no. 2859) and p-IKKα/β (catalog no. 2697) were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Goat anti-rabbit Alexa Fluor 568 [IgG heavy and light chains (H&L)] (catalog no. A-11036) was obtained from Invitrogen (Thermo Fisher Scientific, Inc.).

 Preparation of S. miltiorrhiza extract

Dried roots of S. miltiorrhiza Bunge were purchased from Kwangmyungdang Medicinal Herbs Co., Ltd. (Ulsan, Korea) and authenticated by Professor Guem-San Lee (Department of Herbology, Wonkwang University School of Korean Medicine, Iksan, Korea): A voucher specimen (WKU120302-SM201406A) was deposited at the Department of Herbology, College of Korean Medicine, Wonkwang University (Iksan, Korea). S. miltiorrhiza Radix powder (50 g) was extracted by sonication in 500 ml of 70% aqueous ethanol for 2 h, and then filtered through paper. This procedure was repeated twice. Liquid from the extracted solution was evaporated under 40 mmHg by rotary evaporator, and the resulting product was freeze-dried. The final extraction yield was 6.54% (w/w).

 Determination of cell viability

MCF-7 cells were seeded on 96-well plates (1.5×104 cells/well) and treated with 1, 5, 10, 25 and 50 µg/ml SME for 24 h at 37°C. Then, 100 µl EZ-CyTox assay reagent (Daeil Lab Service Co., Ltd., Seoul, Republic of Korea) was added 100 times diluted to the plate wells. Next, the cells were incubated for 30 min at 37°C prior to measuring the absorbance with a 540-nm filter in an ELISA reader (Molecular Devices, LLC, Sunnyvale, CA, USA).

 Zymography

To analyze the proteolytic activity of MMP-9, zymography was performed as previously described (35). Areas of gelatinase activity were detected as a white zone in a dark blue field.

 Western blot analysis

Total protein extracts were prepared using an ice-cold M-PER Mammalian Protein Extraction Reagent (Pierce; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. Proteins were quantified using a BioSpec-nano Micro-volume Spectrophotometer (Shimadzu; Columbia, USA). For each lane, 20 µg protein was used. The protein samples were separated using SDS-PAGE (10% gel) and transferred to Hybond™ polyvinylidene fluoride membranes. The membranes were blocked with 2% bovine serum albumin (Sigma-Aldrich; Merck KGaA) or 5% skim milk for 2 h at 4°C. Membranes were then incubated overnight at 4°C with primary antibodies. β-actin (catalog no. A2228) was purchased from Sigma-Aldrich (Merck KGaA). MMP-9 (catalog no. 12759), IKKα (catalog no. 2682), IKKβ (catalog no. 2678), PCNA (catalog no. 7907), IκBα (catalog no. 371) and p65 (catalog no. 372) were obtained from Santa Cruz Biotechnology, Inc. JNK (catalog no. 9252), p38 (catalog no. 9212), ERK (catalog no. 9102), phosphorylated (p)-JNK (catalog no. 9252), p-p38 (catalog no. 9211), p-ERK (catalog no. 9101), p-c-Jun (catalog no. 9261), p-IκBα (catalog no. 2859) and p-IKKα/β (catalog no. 2697) were purchased from Cell Signaling Technology, Inc. All Antibodies used were diluted at 1:2,000. Protein expression levels were measured by Mini HD6 image analyzer using Alliance 1D software (UVItec, Cambridge, UK) with Immobilon™ Western Chemilumi nescent HRP Substrate (enhanced chemiluminescence) kit (EMD Millipore, Billerica, MA, USA).

 Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

RNA isolation from cells was performed using the FastPure™ RNA kit (Takara Bio, Inc., Otsu, Japan). Complementary DNA was synthesized using a PrimeScript™ RT Reagent kit (Takara Bio, Inc.). qPCR analysis was performed using the StepOnePlus™ Real-Time PCR System and SYBR Green (both Applied Biosystems; Thermo Fisher Scientific, Inc.) to determine mRNA levels. The thermocycling conditions were as follows: 50°C for 2 min and 95°C for 10 min, followed by 50 cycles of 95°C for 15 sec and 60°C for 1 min. The primers used were as follows: MMP-9 (NM 004994) sense, 5′-CCTGGAGACCTGAGAACCAATCT-3′ and antisense, 5′-CCACCCGAGTGTAACCATAGC-3′; and GAPDH (NM 002046) sense, 5′-ATGGAAATCCCATCACCATCTT-3′ and antisense, 5′-CGCCCCACTTGATTTTGG-3′. The mRNA levels were normalized to the GAPDH housekeeping gene expression levels. The method of quantification was 2−ΔΔCq method (36).

 Automated image acquisition and processing

Cells were fixed with 4% paraformaldehyde at room temperature for 30 min, and then washed three times with cold PBS. Next, the cells were incubated for 45 min at room temperature with blocking buffer to prevent nonspecific antibody binding. Then, anti-p-c-Jun (red) antibodies (dilution, 1:1,000) were added and the cells were incubated for 24 h at 4°C. Subsequently, the cells were washed three times and then incubated for 1 h at room temperature with DAPI (blue) and 1:1,000 diluted goat anti-rabbit Alexa Fluor 568 (IgG H&L) in 0.1% triton X-100 for nuclear and p-c-Jun staining. Images were captured by an ArrayScan™ VTI system using Cellomics VHCS: View Software, version 1.6.30 (Cellomics, Inc., Pittsburgh, PA, USA).

 Cytoplasmic and nuclear fractionation

MCF-7 cells (2×106) were treated with SME and/or TPA for 4 h at 37°C. Following this, the cells were centrifuged at 1,500 × g for 5 min at 4°C. Nuclear and cytoplasmic extracts were separated by using NE-PER Nuclear and Cytoplasmic Extraction Reagent (Pierce; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol.

 Invasion and migration assays

The invasion (35) and migration assays (37) were performed as previously described. Cell growth medium (0.5 ml) with cells was added to the upper chamber, and medium with TPA alone or with SME was added to bottom wells.

 Statistical analysis

The data were analyzed by one-way analysis of variance and Duncan's multiple range tests using SAS software, version 9.1; (SAS Institute Inc., Cary, NC, USA). P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Effects of SME on TPA-induced MMP-9 expression and secretion in MCF-7 cells

The treatment of cells with SME did not affect cell viability until concentrations reached 50 µg/ml (Fig. 1A). On that basis, an SME concentration of 50 µg/ml was used for subsequent experiments. In order to investigate the effect of SME on the expression of MMP-9, cells were pretreated with SME for 1 h and then incubated with TPA for 24 h at 37°C. TPA-mediated expression/secretion of MMP-9 was decreased by pre-treatment with SME (Fig. 1B). qPCR analysis revealed that SME significantly reduced the levels of MMP-9 mRNA expression induced by TPA (Fig. 1C).

 Effects of SME on the TPA-mediated MAPK signaling pathway

To confirm whether SME is involved in MAPK activation, western blot analysis was performed. Exposure to TPA for 15 or 30 min markedly elevated the phosphorylation levels of p38/JNK/ERK, and pre-treatment with SME markedly decreased them (Fig. 2).

 Effects of SME on TPA-induced NF-κB and AP-1 activation

To confirm this TPA-induced activation of NF-κB (p65/p50) and AP-1 (c-Jun/c-Fos), immunofluorescence and western blotting were used. TPA induced substantial p-c-Jun expression, whereas pre-treatment with SME blocked it (Fig. 3A and B). Pre-treatment with SME did not affect the translocation of p65 into the nucleus by TPA (Fig. 3B). Additionally, SME did not affect the levels of p-IKKαβ, p-IκBα or IκBα induced by TPA (Fig. 3C). These results suggested that SME inhibited TPA-induced MMP-9 expression by blocking AP-1 activation.

 Effect of SME on TPA-induced MCF-7 cell invasion/migration in vitro

To demonstrate whether SME inhibits the invasion and migration abilities of MCF-7 cells, in vitro invasion and migration assays were performed. Subsequent to treatment of the cells with TPA, the levels of cell invasion and migration were significantly increased. However, the invasion and migration abilities of cells treated with 50 µg/ml SME and TPA was considerably lower compared with that of cells treated with TPA (Fig. 4).

 Discussion

In the present study, it was revealed that SME blocked TPA-induced cell invasion and MMP-9 expression through inhibition of the MAPK/AP-1 signaling pathway. Concurrently, SME did not affect NF-κB signaling. These results suggest that SME blocks cell invasion by suppressing MMP-9 expression, mediated by the activity of the MAPK/AP-1 signaling pathway, in MCF-7 breast cancer cells.

The ECM provides biochemical and physical barriers to the proliferation and spread of cancer cells, and cancer cell invasion requires its degradation (38,39). Basement membranes consist of various proteins such as collagen, gelatin and other ECM components that are degraded by MMPs. The production of MMPs is tightly controlled by non-specific protease inhibitors or tissue-specific MMP inhibitors (40–43). When this regulation becomes impaired, MMP expression in cancer cells increases abnormally in response to various factors (21–24). In previous studies, this expression was increased by growth factors, inflammatory cytokines, phorbol esters and different signaling pathways in breast cancer cells (44–46). MMP-9 decomposes gelatin and accelerates breast cancer cell invasion (47). Therefore, regulation of MMP-9 expression may be important in treatment strategies for tumor metastasis. Songyou Yin, an herbal compound including S. miltiorrhiza, inhibits tumor invasion via the downregulation of MMPs in hepatocellular carcinoma (48). A previous study reported that SME extracts inhibit the proliferation of MCF-7 cells at a concentration of 5 µg/ml (49). However, the present study confirmed that the inhibitory effect of SME on cell invasion at a concentration of 50 µg/ml does not affect the toxicity of MCF-7 cells. The difference in the concentration of SME for cytotoxicity is considered to be caused by the change of the components depending on the difference of purification processes. The present study suggested that SME inhibited TPA-induced expression of MMP-9 in MCF-7 breast cancer cells (Fig. 1). These results demonstrated that SME has the ability to regulate MMPs.

It has been indicated in several previous studies that the active component of S. miltiorrhiza modulates the MAPK families, including ERK, JNK and p38 kinase. MAPK is involved in cell invasion and protease secretion processes (50,51). In MCF-7 breast cancer cells, the MAPK signaling pathway is activated by protein phosphorylation, which in turn is modulated by TPA (22,52). Previous studies have implicated MAPK in cancer metastasis (19,21,45). In the present study, SME suppressed the TPA-induced phosphorylation of ERK, JNK and p38 in MCF-7 breast cancer cells (Fig. 2).

MAPK families serve an important role in the activation of AP-1. ERK enhances AP-1 activation through c-Fos, whereas JNK leads to the phosphorylation of c-Jun (53). The overexpression of c-Jun enhances MMP-9 expression and in vitro chemo-invasion (54). In the present study, SME blocked TPA-induced c-Jun phosphorylation (Fig. 3). NF-κB is a transcription factor that serves a pivotal role in inducing the expression of MMP-9 (47,55). In the present study, treatment with SME did not inhibit TPA-induced phosphorylation of IKKαβ/IκBα, degradation of IκBα or nuclear translocation of p65NF-κB. These data suggest that SME specifically inhibits the MAPK/AP-1 signaling pathway in TPA-induced MCF-7 breast cancer cells. Previously, Tanshinone II-A demonstrated an inhibitory effect on the invasion and metastasis of human carcinoma cells (8,9). However, the mechanism for that effect was not known in breast cancer. Furthermore, Tanshinone II-A is an alcohol extract of the root of the traditional Chinese medicinal plant S. miltiorrhiza Bunge. These results indicate that S. miltiorrhiza may regulate the invasion abilities of breast cancer. Therefore, the present study assessed the effect of SME on TPA-stimulated cell metastasis in MCF-7 breast cancer cells, and the results indicated that SME inhibited cell invasion (Fig. 4). These findings demonstrated that SME attenuated TPA-induced MMP-9 expression and invasion in MCF-7 breast cancer cells by inhibiting MAPK/AP-1 activation, and revealed the potential use of SME as a traditional therapeutic agent in inhibiting breast cancer metastasis.

 Acknowledgements

The present study was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Nuclear Research & Development Program of the National Research Foundation (grant no. NRF-2012M2A2A6011335) and by the Korean government (the Ministry of Education, Science Technology); grant no. 2011-0030130), Republic of Korea.

 References YanXDan Shen (Salvia miltiorrhiza) in Medicine1SpringerThe Netherlands2016 ParkCHKimDHParkMHKimMKKimNDKimCMTanakaTYokozawaTChungHYMoonHRChinese prescription Kangen-karyu and Salviae Miltiorrhizae Radix improve age-related oxidative stress and inflammatory response through the PI3K/Akt or MAPK pathwaysAm J Chin Med429871005201410.1142/S0192415X1450062125004887 XipingZYanPXinmeiHGuanghuaFMeiliMJieNFangjieZEffects of dexamethasone and Salvia miltiorrhizae on the small intestine and immune organs of rats with severe acute pancreatitisInflammation33259266201010.1007/s10753-010-9180-920127399 GuJLiJCTanRFanLNZhangXEffects of combination of Puerariae lobatae radix and Salviae miltiorrhizae radix et rhizoma on lipid metabolism in atherosclerotic quailsZhongguo Zhong Yao Za Zhi38393939422013(In Chinese)24558880 WuCFBohnertSThinesEEfferthTCytotoxicity of Salvia miltiorrhiza against multidrug-resistant cancer cellsAm J Chin Med44871894201610.1142/S0192415X1650048827222067 GeYYangBChenZChengRCryptotanshinone suppresses the proliferation and induces the apoptosis of pancreatic cancer cells via the STAT3 signaling pathwayMol Med Rep1277827788201526459366 GaoHSunWZhaoWHaoWLeungCHLuJChenXTotal tanshinones-induced apoptosis and autophagy via reactive oxygen species in lung cancer 95D CellsAm J Chin Med4312651279201510.1142/S0192415X1550072X26394653 YuxianXFengTRenLZhengcaiLTanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivoTumori95789795200920210245 ShanYFShenXXieYKChenJCShiHQYuZPSongQTZhouMTZhangQYInhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cellsActa Pharmacol Sin3015371542200910.1038/aps.2009.13919820721 NizamutdinovaITLeeGWLeeJSChoMKSonKHJeonSJKangSSKimYSLeeJHSeoHGTanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion moleculesCarcinogenesis2918851892200810.1093/carcin/bgn15118586687 NizamutdinovaITLeeGWSonKHJeonSJKangSSKimYSLeeJHSeoHGChangKCKimHJTanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cellsInt J Oncol33485491200818695877 RedigAJMcAllisterSSBreast cancer as a systemic disease: A view of metastasisJ Intern Med274113126201310.1111/joim.1208423844915 SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin64929201410.3322/caac.2120824399786 LeberMFEfferthTMolecular principles of cancer invasion and metastasis (Review)Int J Oncol34881895200919287945 ChambersAFMatrisianLMChanging views of the role of matrix metalloproteinases in metastasisJ Natl Cancer Inst8912601270199710.1093/jnci/89.17.12609293916 WoodhouseECChuaquiRFLiottaLAGeneral mechanisms of metastasisCancer80(8 Suppl)S1529S1537199710.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.3.CO;2-# YanCBoydDDRegulation of matrix metalloproteinase gene expressionJ Cell Physiol2111926200710.1002/jcp.2094817167774 OverallCMDeanRADegradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancerCancer Metastasis Rev256975200610.1007/s10555-006-7890-016680573 HongSParkKKMagaeJAndoKLeeTSKwonTKKwakJYKimCHChangYCAscochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: Inhibitory effects of ascochlorin on the invasion of renal carcinoma cellsJ Biol Chem2802520225209200510.1074/jbc.M41398520015863510 RoyRYangJMosesMAMatrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancerJ Clin Oncol2752875297200910.1200/JCO.2009.23.555619738110 LiuJFCrépinMLiuJMBarritaultDLedouxDFGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathwayBiochem Biophys Res Commun29311741182200210.1016/S0006-291X(02)00350-912054499 PrzybylowskaKKlucznaAZadroznyMKrawczykTKuligARykalaJKolacinskaAMorawiecZDrzewoskiJBlasiakJPolymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancerBreast Cancer Res Treat956572200610.1007/s10549-005-9042-616267613 KimSChoiJHKimJBNamSJYangJHKimJHLeeJEBerberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cellsMolecules1329752985200810.3390/molecules1312297519052522 KimSChoiJHLimHILeeSKKimWWChoSKimJSKimJHChoeJHNamSJEGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell lineCell Signal21892898200910.1016/j.cellsig.2009.01.03419385051 ChungTWMoonSKChangYCKoJHLeeYCChoGKimSHKimJGKimCHNovel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanismFASEB J1816701681200410.1096/fj.04-2126com15522912 NohEMChungEYYounHJJungSHHurHLeeYRKimJSCis-guggulsterone inhibits the IKK/NF-kappaB pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF-7 breast cancer cells: Guggulsterone regulates MMP-9 expression in an isomer-specific mannerInt J Mol Med31393399201323242121 HessJAngelPSchorpp-KistnerMAP-1 subunits: Quarrel and harmony among siblingsJ Cell Sci11759655973200410.1242/jcs.0158915564374 LinCWHouWCShenSCJuanSHKoCHWangLMChenYCQuercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cellsCarcinogenesis2918071815200810.1093/carcin/bgn16218628248 LeeSOJeongYJKimMKimCHLeeISSuppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expressionBiochem Biophys Res Commun36610191024200810.1016/j.bbrc.2007.12.06818088599 OhJHChungASSteinbrennerHSiesHBrenneisenPThioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblastsArch Biochem Biophys423218226200410.1016/j.abb.2003.12.02614871484 HimelsteinBPLeeEJSatoHSeikiMMuschelRJTumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeatClin Exp Metastasis16169177199810.1023/A:10065763054059514098 JacobsMDHarrisonSCStructure of an IkappaBalpha/NF-kappaB complexCell95749758199810.1016/S0092-8674(00)81698-09865693 KimHRKimJMKimMSHwangJKParkYJYangSHKimHJRyuDGLeeDSOhHSaussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-kappaB-dependent MMP-9 expression in MCF-7 breast cancer cellsBMC Complement Altern Med14170201410.1186/1472-6882-14-17024885456 LeeYRNohEMOhHJHurHKimJMHanJHHwangJKParkBHParkJWYounHJDihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expressionBiochem Biophys Res Commun405552557201110.1016/j.bbrc.2011.01.06521262201 KimJMNohEMKimHRKimMSSongHKLeeMYangSHLeeGSMoonHCKwonKBLeeYRSuppression of TPA-induced cancer cell invasion by peucedanum japonicum thunb. Extract through the inhibition of PKCα/NF-κB-dependent MMP-9 expression in MCF-7 cellsInt J Mol Med37108114201626717978 LivakKLSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) methodMethods25402408200110.1006/meth.2001.126211846609 NohEMLeeYRHongOYJungSHYounHJKimJSAurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cellsOncol Rep34803810201526044736 WoessnerJFJrMatrix metalloproteinases and their inhibitors in connective tissue remodelingFASEB J52145215419911850705 ZwiefelKJanniWCurrent standards in the treatment of breast cancerMed Monatsschr Pharm34280288quiz 289–2902011(In German)21853882 DeryuginaEIQuigleyJPMatrix metalloproteinases and tumor metastasisCancer Metastasis Rev25934200610.1007/s10555-006-7886-916680569 KöhrmannAKammererUKappMDietlJAnackerJExpression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureBMC Cancer9188200910.1186/1471-2407-9-18819531263 LombardCSaulnierJWallachJAssays of matrix metalloproteinases (MMPs) activities: A reviewBiochimie87265272200510.1016/j.biochi.2005.01.00715781313 DuffyMJMcCarthyKMatrix metalloproteinases in cancer: Prognostic markers and targets for therapy (Review)Int J Oncol121343134819989592197 MignattiPRifkinDBBiology and biochemistry of proteinases in tumor invasionPhysiol Rev7316119519938419965 ChoHJKangJHKwakJYLeeTSLeeISParkNGNakajimaHMagaeJChangYCAscofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanismsCarcinogenesis2811041110200710.1093/carcin/bgl21717114644 MoNLiZQLiJCaoYDCurcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cellsAsian Pac J Cancer Prev1357095714201210.7314/APJCP.2012.13.11.570923317243 LunguGCovaledaLMendesOMartini-StoicaHStoicaGFGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1Mol Carcinog47424435200810.1002/mc.2039818041768 HuangXYWangLHuangZLZhengQLiQSTangZYHerbal extract ‘Songyou Yin’ inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potentialJ Cancer Res Clin Oncol13512451255200910.1007/s00432-009-0566-819277711 YangWJuJHJeonMJHanXShinIDanshen (Salvia miltiorrhiza) extract inhibits proliferation of breast cancer cells via modulation of Akt activity and p27 levelPhytother Res24198204201019610045 CobbMHGoldsmithEJHow MAP kinases are regulatedJ Biol Chem2701484314846199510.1074/jbc.270.25.148437797459 SegerRBienerYFeinsteinRHanochTGazitAZickYDifferential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-tetradecanoylphorbol-13-acetate (TPA) and insulin. Evidence for involvement of a TPA-stimulated protein-tyrosine kinaseJ Biol Chem2702832528330199510.1074/jbc.270.47.283257499332 JemalAMurrayTWardESamuelsATiwariRCGhafoorAFeuerEJThunMJCancer statistics, 2005CA Cancer J Clin551030200510.3322/canjclin.55.1.1015661684 YaoJXiongSKlosKNguyenNGrijalvaRLiPYuDMultiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cellsOncogene2080668074200110.1038/sj.onc.120494411781819 SmithLMWiseSCHendricksDTSabichiALBosTReddyPBrownPHBirrerMJcJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeOncogene1860636070199910.1038/sj.onc.120298910557095 EberhardtWHuwilerABeckKFWalpenSPfeilschifterJAmplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathwaysJ Immunol16557885797200010.4049/jimmunol.165.10.578811067938

SME inhibits TPA-induced MMP-9 expression in MCF-7 cells. (A) SME was treated at various concentrations (0, 1, 5, 10, 25 and 50 µg/ml) for 24 h. An MTT assay was used to measure cell viability. (B) MCF-7 cells in a monolayer were treated with the indicated SME concentrations in the presence of TPA for 24 h. Cell lysates were analyzed by western blotting with an anti-MMP-9 antibody. The blot was re-probed with an anti-β-actin antibody to confirm equal loading amounts. Conditioned medium was prepared and used for gelatin zymography. (C) MMP-9 mRNA levels were analyzed by quantitative polymerase chain reaction using GAPDH mRNA as an internal control. Each value represents the mean ± standard error of the mean of three independent experiments. *P<0.05 vs. TPA only. SME, Salvia miltiorrhiza extract; TPA, 12-O-tetradecanoylphorbol-13-acetate; MMP-9, matrix metalloproteinase-9; Zymo, zymography.

SME inhibits TPA-induced mitogen-activated protein kinase activation in MCF-7 cells. Cells were pretreated with SME for 1 h and then stimulated with TPA for 15 and 30 min. Western blotting for p-p38, p-ERK and p-JNK was performed as described in the Materials and methods section. SME, Salvia miltiorrhiza extract; TPA, 12-O-tetradecanoylphorbol-13-acetate; p, phosphorylated; ERK, extracellular signal-related kinase; JNK, c-Jun N-terminal kinase.

SME suppresses TPA-induced transcriptional activation of MMP-9 by inhibiting AP-1. (A) Cells were pretreated with SME in the presence of TPA. Following 4 h of incubation, the expression of p-c-Jun in the nucleus was assessed by immunofluorescence analysis (magnification, ×10). (B) Cells were pretreated with SME for 1 h and then exposed to TPA for 4 h. Western blotting was performed to determine the nuclear levels of p65 and activator protein 1 (p-c-Jun) subunits. PCNA was used as loading control. (C) Cells were pretreated with SME for 1 h and then stimulated with TPA for 4 h. Western blotting was performed to determine the cytoplasmic levels of IκBα, p-IκBα, IKKα, IKKβ and p-IKKαβ. SME, Salvia miltiorrhiza extract; TPA, 12-O-tetradecanoylphorbol-13-acetate; p, phosphorylated; PCNA, proliferating cell nuclear antigen; IKK, inhibitory κ B kinase; IκBα, inhibitory κ B α; p65, nuclear factor-κB p65 subunit.

SME inhibits TPA-induced invasion and migration in MCF-7 cells. Change in (A) invasion and (B) migration in MCF-7 cells (magnification, ×10). Each value represents the mean ± standard error of the mean of three independent experiments. #P<0.05 vs. control, *P<0.05 vs. TPA only. SME, Salvia miltiorrhiza extract; TPA, 12-O-tetradecanoylphorbol-13-acetate.